# Pharmaceutical Components at Risk for Melamine Contamination:  Guidance for Industry - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/pharmaceutical-components-at-risk-for-melamine-contamination-guidance-for-industry/b67e8a1e-249f-4a0f-b5e4-4c87ca550b18

> FDA guidance document: Pharmaceutical Components at Risk for Melamine Contamination:  Guidance for Industry. Issue date: August 06, 2009. Get complete insights and analysis.

---

## Details

- Title: Pharmaceutical Components at Risk for Melamine Contamination:  Guidance for Industry
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2009-08-06
- Last Changed: 2020-05-15
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2009-D-0354">FDA-2009-D-0354</a>

## Related Documents

- [Process Validation: General Principles and Practices:  Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/process-validation-general-principles-and-practices-guidance-for-industry/38024bdb-dc3f-40dd-b115-6125cb5be8bb)
- [Heparin for Drug and Medical Device Use:  Monitoring Crude Heparin for Quality:  Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/heparin-for-drug-and-medical-device-use-monitoring-crude-heparin-for-quality-guidance-for-industry/28019717-ce5d-43c7-9595-479e33fbe847)
- [Non-Penicillin Beta-Lactam Drugs: A CGMP Framework for Preventing Cross-Contamination:  Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/non-penicillin-beta-lactam-drugs-a-cgmp-framework-for-preventing-cross-contamination-guidance-for-industry/8f4551af-85d4-4a2c-9a05-f4a01a143967)